MedTrace Logo

Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation

NCT06723145 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2025-02-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are scheduled for abdominal surgery.

Conditions

  • Antiplatelet Agents
  • Perioperative Care

Interventions

DRUG

Aspirin

perioperative aspirin continuation

DRUG

Aspirin interruption

Aspirin interruption 5-7 days before surgery

Sponsors & Collaborators

  • Kyoto University

    lead OTHER

Principal Investigators

  • Hiroki Shiomi, MD, PhD · Kyoto University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-20
Primary Completion
2027-02-28
Completion
2027-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06723145 on ClinicalTrials.gov